NCT00004772
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +15 more
- Locations
-
Not specified
Clinical trial condition
Demyelinating Diseases
Explore clinical trials studying Demyelinating Diseases. Study availability and eligibility vary by location and protocol.
2,931 public trials
462 recruiting studies
Demyelinating Diseases trial results
NCT00004816
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +11 more
- Locations
-
Not specified
NCT00017628
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +11 more
- Locations
-
- Northwestern Memorial Hospital Chicago, Illinois, United States
- Rush-Presbyterian-St. Luke's Medical Center Chicago, Illinois, United States
NCT00004939
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +15 more
- Locations
-
Not specified
NCT00004814
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +11 more
- Locations
-
Not specified
NCT00006057
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +25 more
- Locations
-
- Mount Sinai School of Medicine New York, United States
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +11 more
- Locations
-
- City of Hope National Medical Center Duarte, California, United States
- University of Colorado Cancer Center Denver, Colorado, United States
- Washington University Barnard Cancer Center St Louis, Missouri, United States
- University of Nebraska Medical Center Omaha, Nebraska, United States
Active, Not Recruiting
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Relapsing Multiple Sclerosis (RMS)
NCT04544436
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
- Locations
-
- North Central Neurology Associates Cullman, Alabama, United States
- Alabama Neurology Associates Homewood, Alabama, United States
- 21st Century Neurology Phoenix, Arizona, United States
- Profound Research, LLC Carlsbad, California, United States
Active, Not Recruiting
Comparison Between ABP 692 and Ocrevus® (Ocrelizumab)
NCT06700343
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
- Locations
-
- University of South Alabama Mobile, Alabama, United States
- Clinical Endpoints, LLC Scottsdale, Arizona, United States
- Profound Research - Neurology Center of Southern California Carlsbad, California, United States
- Mountain Neurological Research Center Basalt, Colorado, United States
Active, Not Recruiting
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis (PPMS)
NCT04548999
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +9 more
- Locations
-
- Alabama Neurology Associates Homewood, Alabama, United States
- 21st Century Neurology Phoenix, Arizona, United States
- University of California Irvine Irvine, California, United States
- Stanford University Medical Center Stanford, California, United States